Bevacizumab in Ovarian Cancer: State of the Art and Unanswered Questions

Publisher： Karger

E-ISSN： 1421-9794|62|2|111-120

ISSN： 0009-3157

Source： Chemotherapy, Vol.62, Iss.2, 2016-10, pp. : 111-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unanswered Questions

By  

The Australian Journal of Hospital Pharmacy, Vol. 30, Iss. 6, 2000-12 ,pp. : 289-289

John Wiley & Sons Inc

Access to resources Recommend Favorite

Differentiated Thyroid Cancer—Treatment: State of the Art

By Schmidbauer Benedikt   Menhart Karin   Hellwig Dirk   Grosse Jirka  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1292-1292

MDPI

Access to resources Recommend Favorite

State of Art of Cancer Pharmacogenomics in Latin American Populations

By López-Cortés Andrés   Guerrero Santiago   Redal María Ana   Alvarado Angel Tito   Quiñones Luis Abel  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-05 ,pp. : 639-639

MDPI

Access to resources Recommend Favorite

Fish, Mercury, Selenium and Cardiovascular Risk: Current Evidence and Unanswered Questions

By Mozaffarian Dariush  

International Journal of Environmental Research and Public Health, Vol. 6, Iss. 6, 2009-06 ,pp. : 1894-1916

MDPI

Access to resources Recommend Favorite

The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014

By Trivers Katrina F.   Rodriguez Juan L.   Cox Summer L.   Crane Barbara E.   Duquette Debra  

Healthcare, Vol. 3, Iss. 4, 2015-10 ,pp. : 948-963

MDPI

Access to resources Recommend Favorite